We receive and gladly publish
"The formulations of Biotad capsules and Noctaval are missing compared to what was inventoried by the bankruptcy trustee and 
by the magistrate: why and how was it possible that these medicines are no longer in the warehouse?”
The questions were asked by the drug's scientific representatives - legally assisted by the lawyer Maria Rosaria Pace - of Biomedica Foscama, the pharmaceutical company which, after the bankruptcy recognized by the court of Frosinone, was put up for competitive sale electronically (day 4.4 .2019).
To date, in addition to remaining unresolved, the situation of Biomedica employees and sales agents who have not received various indemnities before the closure declared in the 
September 2018, not all the drugs contained in the company's warehouse and registered by the bankruptcy trustee are still physically present, significantly affecting the sale of the company itself.
The informants therefore ask that their doubts regarding the sale by Biomedica Business Division SRL of the products "Noctaval and Biotad capsules" be dispelled.
(Former ISF Biomedica Foscama press release)
Related news: Biomedical Foscama. Auction sale in April
